Pyrazolo pyridine derivatives as NADPH Oxidase inhibitors

Details for Australian Patent Application No. 2009298008 (hide)

Owner GenkyoTex SA

Inventors Page, Patrick; Orchard, Mike; Laleu, Benoit; Gaggini, Francesca

Agent Watermark

Pub. Number AU-A-2009298008

PCT Pub. Number WO2010/035221

Priority 08164857.8 23.09.08 EP

Filing date 22 September 2009

Wipo publication date 1 April 2010

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/437 (2006.01)

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 13/00 (2006.01) Drugs for disorders of the urinary system

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 19/00 (2006.01) Drugs for skeletal disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 27/00 (2006.01) Drugs for disorders of the senses

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

14 April 2011 PCT application entered the National Phase

  PCT publication WO2010/035221 Priority application(s): WO2010/035221

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009298013-Herbal composition and method for the treatment of viral infection

2009298007-Pyrazolo pyridine derivatives as NADPH Oxidase inhibitors